Overview

A Phase 3 Study to Assess the Efficacy and Safety of PK101 in Patients With Knee Osteoarthritis

Status:
Recruiting
Trial end date:
2022-03-15
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the efficacy and the safety of PK101 in patients with knee osteoarthritis.
Phase:
Phase 3
Details
Lead Sponsor:
PMG Pharm Co., Ltd